Skip to main content
Premium Trial:

Request an Annual Quote

Penguin Computing to Bundle Scyld ClusterWare with ABI's SOLiD Sequencers


Penguin Computing said this week that it has signed an OEM agreement with Life Technologies business unit Applied Biosystems under which it will bundle its Scyld ClusterWare cluster-management software with ABI's SOLiD sequencer.

Scyld ClusterWare is designed to help deploy and manage Linux clusters. The company said that it is now "seamlessly integrated with the SOLiD platform to execute primary and secondary analysis tasks such as image processing and sequence alignment."

According to ABI's most recent specification sheet for the SOLiD, the system comes with a head node and three compute nodes running 64-bit Linux.

The head node is a Dell PowerEdge 1950 with two Intel Xeon Dual Quad Core processors, while the compute nodes each have a single Intel Xeon Dual Quad Core processor.

Timothy Burcham, senior director of SOLiD R&D at Life Technologies, said in a statement that the firm evaluated "multiple cluster management products" before opting for Scyld ClusterWare.

He said that the software offers a "robust, easy-to-use" architecture, "which we believe will resonate well with researchers using the SOLiD platform for a wide variety of applications."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.